Lipid-peptide nanocomplexes for mRNA delivery in vitro and in vivo-Reference-Cited by-同舟云学术

Lipid-peptide nanocomplexes for mRNA delivery in vitro and in vivo

Published:2022-08 Issue: Volume:348 Page:786-797
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Grant-Serroukh Dania,Hunter Morag R.,Maeshima Ruhina,Tagalakis Aristides D.,Aldossary Ahmad M.,Allahham Nour,Williams Gareth R.,Edbrooke Mark,Desai Arpan,Hart Stephen L.

Funder

University College London

AstraZeneca

Science Foundation Ireland

NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research

Great Ormond Street Hospital for Children

Engineering and Physical Sciences Research Council

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference44 articles.

1. mRNA-based therapeutics--developing a new class of drugs;Sahin;Nat. Rev. Drug Discov.,2014

2. SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness;Corbett;Nature,2020

3. CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis;Gillmore;N. Engl. J. Med.,2021

4. Stacking up CRISPR against RNAi for therapeutic gene inhibition;Haussecker;FEBS J.,2016

5. Gene editor injected into the body treats disease;Kaiser;Science,2021

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Leveraging high-throughput screening technologies in targeted mRNA delivery;Materials Today Bio;2024-06

2. Receptor Targeting Using Copolymer-Modified Gold Nanoparticles for pCMV-Luc Gene Delivery to Liver Cancer Cells In Vitro;International Journal of Molecular Sciences;2024-05-04

3. Evaluation of culture methods and chemical reagent combinations on CRISPR/Cas9 gene editing systems by lipofection in pig zygotes;In Vitro Cellular & Developmental Biology - Animal;2024-04-25

4. Lipid Nanoparticles Efficiently Deliver the Base Editor ABE8e for COL7A1 Correction in Dystrophic Epidermolysis Bullosa Fibroblasts In Vitro;Journal of Investigative Dermatology;2024-04

5. A combination of PD-L1-targeted IL-15 mRNA nanotherapy and ultrasound-targeted microbubble destruction for tumor immunotherapy;Journal of Controlled Release;2024-03